Global Flu Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
According to APO Research, The global Flu Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
Report Scope
This report aims to provide a comprehensive presentation of the global market for Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Vaccine.
The Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
According to APO Research, The global Flu Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
Report Scope
This report aims to provide a comprehensive presentation of the global market for Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Vaccine.
The Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Sanofi Pasteur
- CSL
- GSK
- Mylan
- Hulan Bio
- AstraZeneca
- CCBIO
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- For Children (6 months to 3 years)
- For Adults and Children over 3 years
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Flu Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Flu Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Flu Vaccine Market by Type
1.3.1 Trivalent Influenza Vaccine
1.3.2 Quadrivalent Influenza Vaccine
1.4 Global Flu Vaccine Market Size by Type
1.4.1 Global Flu Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Flu Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Flu Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Flu Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Flu Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Flu Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Flu Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Flu Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Flu Vaccine Industry Trends
2.2 Flu Vaccine Industry Drivers
2.3 Flu Vaccine Industry Opportunities and Challenges
2.4 Flu Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Flu Vaccine Revenue (2019-2024)
3.2 Global Top Players by Flu Vaccine Sales (2019-2024)
3.3 Global Top Players by Flu Vaccine Price (2019-2024)
3.4 Global Flu Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Flu Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Flu Vaccine Company, Product Type & Application
3.7 Global Flu Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Flu Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Flu Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Flu Vaccine Tier 1, Tier 2, and Tier
4 FLU VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Flu Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Flu Vaccine Historic Market Size by Region
4.2.1 Global Flu Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Flu Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Flu Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Flu Vaccine Forecasted Market Size by Region
4.3.1 Global Flu Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Flu Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Flu Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 FLU VACCINE BY APPLICATION
5.1 Flu Vaccine Market by Application
5.1.1 For Children (6 months to 3 years)
5.1.2 For Adults and Children over 3 years
5.2 Global Flu Vaccine Market Size by Application
5.2.1 Global Flu Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Flu Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Flu Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Flu Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Flu Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Flu Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Flu Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Flu Vaccine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Comapny Information
6.1.2 Sanofi Pasteur Business Overview
6.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments
6.2 CSL
6.2.1 CSL Comapny Information
6.2.2 CSL Business Overview
6.2.3 CSL Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Flu Vaccine Product Portfolio
6.2.5 CSL Recent Developments
6.3 GSK
6.3.1 GSK Comapny Information
6.3.2 GSK Business Overview
6.3.3 GSK Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Flu Vaccine Product Portfolio
6.3.5 GSK Recent Developments
6.4 Mylan
6.4.1 Mylan Comapny Information
6.4.2 Mylan Business Overview
6.4.3 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Flu Vaccine Product Portfolio
6.4.5 Mylan Recent Developments
6.5 Hulan Bio
6.5.1 Hulan Bio Comapny Information
6.5.2 Hulan Bio Business Overview
6.5.3 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hulan Bio Flu Vaccine Product Portfolio
6.5.5 Hulan Bio Recent Developments
6.6 AstraZeneca
6.6.1 AstraZeneca Comapny Information
6.6.2 AstraZeneca Business Overview
6.6.3 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AstraZeneca Flu Vaccine Product Portfolio
6.6.5 AstraZeneca Recent Developments
6.7 CCBIO
6.7.1 CCBIO Comapny Information
6.7.2 CCBIO Business Overview
6.7.3 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 CCBIO Flu Vaccine Product Portfolio
6.7.5 CCBIO Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Flu Vaccine Sales by Country
7.1.1 North America Flu Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Flu Vaccine Sales by Country (2019-2024)
7.1.3 North America Flu Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Flu Vaccine Market Size by Country
7.2.1 North America Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Flu Vaccine Market Size by Country (2019-2024)
7.2.3 North America Flu Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Flu Vaccine Sales by Country
8.1.1 Europe Flu Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Flu Vaccine Sales by Country (2019-2024)
8.1.3 Europe Flu Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Flu Vaccine Market Size by Country
8.2.1 Europe Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Flu Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Flu Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Flu Vaccine Sales by Country
9.1.1 Asia-Pacific Flu Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Flu Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Flu Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Flu Vaccine Market Size by Country
9.2.1 Asia-Pacific Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Flu Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Flu Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Flu Vaccine Sales by Country
10.1.1 Latin America Flu Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Flu Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Flu Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Flu Vaccine Market Size by Country
10.2.1 Latin America Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Flu Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Flu Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Flu Vaccine Sales by Country
11.1.1 Middle East and Africa Flu Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Flu Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Flu Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Flu Vaccine Market Size by Country
11.2.1 Middle East and Africa Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Flu Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Flu Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Flu Vaccine Value Chain Analysis
12.1.1 Flu Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Flu Vaccine Production Mode & Process
12.2 Flu Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Flu Vaccine Distributors
12.2.3 Flu Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Flu Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Flu Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Flu Vaccine Market by Type
1.3.1 Trivalent Influenza Vaccine
1.3.2 Quadrivalent Influenza Vaccine
1.4 Global Flu Vaccine Market Size by Type
1.4.1 Global Flu Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Flu Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Flu Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Flu Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Flu Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Flu Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Flu Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Flu Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Flu Vaccine Industry Trends
2.2 Flu Vaccine Industry Drivers
2.3 Flu Vaccine Industry Opportunities and Challenges
2.4 Flu Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Flu Vaccine Revenue (2019-2024)
3.2 Global Top Players by Flu Vaccine Sales (2019-2024)
3.3 Global Top Players by Flu Vaccine Price (2019-2024)
3.4 Global Flu Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Flu Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Flu Vaccine Company, Product Type & Application
3.7 Global Flu Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Flu Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Flu Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Flu Vaccine Tier 1, Tier 2, and Tier
4 FLU VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Flu Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Flu Vaccine Historic Market Size by Region
4.2.1 Global Flu Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Flu Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Flu Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Flu Vaccine Forecasted Market Size by Region
4.3.1 Global Flu Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Flu Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Flu Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 FLU VACCINE BY APPLICATION
5.1 Flu Vaccine Market by Application
5.1.1 For Children (6 months to 3 years)
5.1.2 For Adults and Children over 3 years
5.2 Global Flu Vaccine Market Size by Application
5.2.1 Global Flu Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Flu Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Flu Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Flu Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Flu Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Flu Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Flu Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Flu Vaccine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Comapny Information
6.1.2 Sanofi Pasteur Business Overview
6.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments
6.2 CSL
6.2.1 CSL Comapny Information
6.2.2 CSL Business Overview
6.2.3 CSL Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Flu Vaccine Product Portfolio
6.2.5 CSL Recent Developments
6.3 GSK
6.3.1 GSK Comapny Information
6.3.2 GSK Business Overview
6.3.3 GSK Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Flu Vaccine Product Portfolio
6.3.5 GSK Recent Developments
6.4 Mylan
6.4.1 Mylan Comapny Information
6.4.2 Mylan Business Overview
6.4.3 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Flu Vaccine Product Portfolio
6.4.5 Mylan Recent Developments
6.5 Hulan Bio
6.5.1 Hulan Bio Comapny Information
6.5.2 Hulan Bio Business Overview
6.5.3 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hulan Bio Flu Vaccine Product Portfolio
6.5.5 Hulan Bio Recent Developments
6.6 AstraZeneca
6.6.1 AstraZeneca Comapny Information
6.6.2 AstraZeneca Business Overview
6.6.3 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AstraZeneca Flu Vaccine Product Portfolio
6.6.5 AstraZeneca Recent Developments
6.7 CCBIO
6.7.1 CCBIO Comapny Information
6.7.2 CCBIO Business Overview
6.7.3 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 CCBIO Flu Vaccine Product Portfolio
6.7.5 CCBIO Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Flu Vaccine Sales by Country
7.1.1 North America Flu Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Flu Vaccine Sales by Country (2019-2024)
7.1.3 North America Flu Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Flu Vaccine Market Size by Country
7.2.1 North America Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Flu Vaccine Market Size by Country (2019-2024)
7.2.3 North America Flu Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Flu Vaccine Sales by Country
8.1.1 Europe Flu Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Flu Vaccine Sales by Country (2019-2024)
8.1.3 Europe Flu Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Flu Vaccine Market Size by Country
8.2.1 Europe Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Flu Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Flu Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Flu Vaccine Sales by Country
9.1.1 Asia-Pacific Flu Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Flu Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Flu Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Flu Vaccine Market Size by Country
9.2.1 Asia-Pacific Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Flu Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Flu Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Flu Vaccine Sales by Country
10.1.1 Latin America Flu Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Flu Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Flu Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Flu Vaccine Market Size by Country
10.2.1 Latin America Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Flu Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Flu Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Flu Vaccine Sales by Country
11.1.1 Middle East and Africa Flu Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Flu Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Flu Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Flu Vaccine Market Size by Country
11.2.1 Middle East and Africa Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Flu Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Flu Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Flu Vaccine Value Chain Analysis
12.1.1 Flu Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Flu Vaccine Production Mode & Process
12.2 Flu Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Flu Vaccine Distributors
12.2.3 Flu Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
